| Whitesell Long Term Care Pharmacy | |
| 228 W Patrick St, Frederick, Maryland 21701 | |
| (240) 877-7575 |
| Name | Whitesell Long Term Care Pharmacy |
|---|---|
| Organization Name | Fulton Pharmacy, Llc |
| Location | 228 W Patrick St, Frederick, Maryland 21701 |
| Type | Pharmacy |
| Phone | (240) 877-7575 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The study, conducted by Imperial College London on data from 2009 to 2018, looked at a third of a million passenger responses to Customer Satisfaction Surveys from 28 cities across four continents.
AstraZeneca and Abbott announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Older patients at risk of decline and death do not receive recommended medication to treat their chronic health problems about half of the time, according to a study issued by researchers from the RAND Corporation and UCLA.
Two clinical trials of the novel drug romiplostim (Nplate) show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura (ITP), a hematologic disorder that can cause uncontrolled bleeding.
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for sealant, orthobiologic and surgical wound indications, announced today that its patent application U.S.S.N 12/102,157 will issue today and has been assigned U.S. Patent No. 8,961,947.
› Verified 9 days ago
| NPI Number | 1578095576 |
| Organization Name | FULTON PHARMACY, LLC |
| Doing Business As | WHITESELL LONG TERM CARE PHARMACY |
| Type | Pharmacy |
| Address | 228 W Patrick St, Frederick, MD 21701 |
| Phone Number | 240-877-7575 |
News Archive
The study, conducted by Imperial College London on data from 2009 to 2018, looked at a third of a million passenger responses to Customer Satisfaction Surveys from 28 cities across four continents.
AstraZeneca and Abbott announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Older patients at risk of decline and death do not receive recommended medication to treat their chronic health problems about half of the time, according to a study issued by researchers from the RAND Corporation and UCLA.
Two clinical trials of the novel drug romiplostim (Nplate) show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura (ITP), a hematologic disorder that can cause uncontrolled bleeding.
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for sealant, orthobiologic and surgical wound indications, announced today that its patent application U.S.S.N 12/102,157 will issue today and has been assigned U.S. Patent No. 8,961,947.
› Verified 9 days ago
News Archive
The study, conducted by Imperial College London on data from 2009 to 2018, looked at a third of a million passenger responses to Customer Satisfaction Surveys from 28 cities across four continents.
AstraZeneca and Abbott announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Older patients at risk of decline and death do not receive recommended medication to treat their chronic health problems about half of the time, according to a study issued by researchers from the RAND Corporation and UCLA.
Two clinical trials of the novel drug romiplostim (Nplate) show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura (ITP), a hematologic disorder that can cause uncontrolled bleeding.
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for sealant, orthobiologic and surgical wound indications, announced today that its patent application U.S.S.N 12/102,157 will issue today and has been assigned U.S. Patent No. 8,961,947.
› Verified 9 days ago
Cvs Pharmacy #01437 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1460b W Patrick St, Frederick, Maryland 21702 Phone: (301) 662-9522 | |
Cvs Pharmacy #02335 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8032 Liberty Rd, Frederick, Maryland 21701 Phone: (301) 846-0090 | |
Cvs Pharmacy #01484 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 402 S Jefferson St, Frederick, Maryland 21701 Phone: (301) 663-4861 | |
Cvs Pharmacy #02230 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2040 Rosemont Ave, Frederick, Maryland 21702 Phone: (301) 695-4811 | |
Cvs Pharmacy #01518 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 901 W 7th St, Frederick, Maryland 21701 Phone: (301) 694-3390 |